Feb 25, 2020

The Clinical Management of Clonal Hematopoiesis: Creation of a Clonal Hematopoiesis Clinic

Hematology/oncology Clinics of North America
Kelly L BoltonRoss L Levine


The acquisition of mutations in hematologic stem cells (clonal hematopoiesis) is common with normal aging and can be identified as an incidental finding through clinical genetic testing. Clonal hematopoiesis is associated with a heightened risk of developing hematologic neoplasms (especially myeloid) and accelerated atherosclerotic cardiovascular disease. This article discusses a multidisciplinary clinical approach to the management of patients with clonal hematopoiesis. Key areas of research needed to establish evidence-based clinical care guidelines and intervention strategies for individuals with clonal hematopoiesis are discussed.

  • References
  • Citations1


  • We're still populating references for this paper, please check back later.
  • References
  • Citations1


Mentioned in this Paper

Disease Management
Genetic Screening Method
Stem Cells

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

The New England Journal of Medicine
Rupert PhillipsTimothy Chevassut
The New England Journal of Medicine
Bruno CassinatJean-Jacques Kiladjian
© 2020 Meta ULC. All rights reserved